IL140388A0 - Aryl phosphate derivatives of d4t having anti-hiv activity - Google Patents

Aryl phosphate derivatives of d4t having anti-hiv activity

Info

Publication number
IL140388A0
IL140388A0 IL14038899A IL14038899A IL140388A0 IL 140388 A0 IL140388 A0 IL 140388A0 IL 14038899 A IL14038899 A IL 14038899A IL 14038899 A IL14038899 A IL 14038899A IL 140388 A0 IL140388 A0 IL 140388A0
Authority
IL
Israel
Prior art keywords
aryl phosphate
phosphate derivatives
derivatives
group
hiv activity
Prior art date
Application number
IL14038899A
Other languages
English (en)
Original Assignee
Parker Hughes Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Inst filed Critical Parker Hughes Inst
Publication of IL140388A0 publication Critical patent/IL140388A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL14038899A 1998-06-29 1999-06-29 Aryl phosphate derivatives of d4t having anti-hiv activity IL140388A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/107,716 US6030957A (en) 1998-06-29 1998-06-29 Aryl phosphate derivatives of d4T having anti-HIV activity
PCT/US1999/014774 WO2000000501A1 (en) 1998-06-29 1999-06-29 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY

Publications (1)

Publication Number Publication Date
IL140388A0 true IL140388A0 (en) 2002-02-10

Family

ID=22318071

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14038899A IL140388A0 (en) 1998-06-29 1999-06-29 Aryl phosphate derivatives of d4t having anti-hiv activity

Country Status (14)

Country Link
US (7) US6030957A (ru)
EP (1) EP1090018B1 (ru)
JP (1) JP2002519355A (ru)
KR (1) KR20010071673A (ru)
CN (1) CN1314909A (ru)
AT (1) ATE277940T1 (ru)
AU (1) AU4846999A (ru)
BR (1) BR9911685A (ru)
CA (1) CA2336285A1 (ru)
DE (1) DE69920696T2 (ru)
HU (1) HUP0102527A3 (ru)
IL (1) IL140388A0 (ru)
NO (1) NO20006685L (ru)
WO (1) WO2000000501A1 (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038576A1 (en) * 2000-11-13 2002-05-16 Parker Hughes Institute ARYL PHOSPHATE DERIVATIVES OF d4T
US7144874B2 (en) * 2002-10-25 2006-12-05 Parker Hughes Institute Aryl phosphate derivatives of d4T having activity against resistant HIV strains
US20070015733A1 (en) * 1998-06-29 2007-01-18 Parker Hughes Institute Aryl Phosphate Derivatives of d4T having Activity Against Resistant HIV Strains
US6030957A (en) * 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity
WO2000056750A1 (en) * 1999-03-19 2000-09-28 Parker Hughes Institute One pot synthesis of 5'-hydroxy phosphorylated nucleoside derivatives, and compounds formed thereby
US6825177B2 (en) * 2000-10-30 2004-11-30 Parker Hughes Institute Aryl phosphate derivatives of d4T with potent anti-viral activity
MXPA04011731A (es) * 2002-05-28 2005-02-14 Univ Minnesota Polipetidos cris como anticonceptivos e inhibidores de la capacitacion de espermatozoides.
US20030236218A1 (en) * 2002-06-12 2003-12-25 Uckun Fatih M. Aryl phosphate derivatives of d4T with selective activity against adenovirus and HIV
US20040076931A1 (en) * 2002-10-18 2004-04-22 Cashflow Technologies, Inc. Educational interactive games
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
GB0401088D0 (en) 2004-01-19 2004-02-18 Univ Cardiff Phosphoramidate derivatives
WO2006012078A2 (en) * 2004-06-24 2006-02-02 Merck & Co., Inc. Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
US20060046972A1 (en) * 2004-08-31 2006-03-02 Parker Hughes Institute Cytotoxic nucleoside analog compound 003 for treating cancer
WO2006063149A1 (en) 2004-12-09 2006-06-15 Regents Of The University Of Minnesota Nucleosides with antiviral and anticancer activity
EP1866064A4 (en) * 2005-03-09 2009-08-19 Univ California NANOCOMPOSITE MEMBRANES AND METHODS OF MAKING AND USING SAME
US7892618B2 (en) 2005-03-21 2011-02-22 Sony Corporation Deterring theft of optical media
GB0623493D0 (en) * 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
EA201190178A1 (ru) * 2009-03-20 2012-06-29 Алиос Биофарма, Инк. Замещённые нуклеозидные и нуклеотидные аналоги
JP6012605B2 (ja) 2010-09-22 2016-10-25 アリオス バイオファーマ インク. 置換されたヌクレオチドアナログ
WO2012094248A1 (en) * 2011-01-03 2012-07-12 Nanjing Molecular Research, Inc. O-(substituted benzyl) phosphoramidate compounds and therapeutic use
US8980865B2 (en) 2011-12-22 2015-03-17 Alios Biopharma, Inc. Substituted nucleotide analogs
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
EP2827876A4 (en) 2012-03-22 2015-10-28 Alios Biopharma Inc PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG
EP2984097B1 (en) 2013-04-12 2017-03-29 Achillion Pharmaceuticals, Inc. Highly active nucleoside derivative for the treatment of hcv

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707362A (en) 1985-02-15 1987-11-17 Biotek, Inc. Sustained release composition
US4841039A (en) 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4983393A (en) 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
JPH06189998A (ja) 1992-11-06 1994-07-12 C & Co:Yugen コンド―ム
CA2130265A1 (en) 1992-12-18 1994-07-07 Edward E. Knaus Dihydropyrimidine nucleosides with antiviral properties
ZA947572B (en) 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
US5672698A (en) * 1993-11-15 1997-09-30 Bristol-Myers Squibb Co. Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine
US5659023A (en) * 1995-02-01 1997-08-19 Gilead Sciences, Inc. Nucleotide analogues
GB9505025D0 (en) * 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
AU723081B2 (en) 1996-05-09 2000-08-17 Infectio Recherche Inc. Formulation for use in the prevention of pathogen induced diseases including HIV and HSV
US6030957A (en) 1998-06-29 2000-02-29 Wayne Hughes Institute Aryl phosphate derivatives of d4T having anti-HIV activity

Also Published As

Publication number Publication date
US6503890B1 (en) 2003-01-07
HUP0102527A2 (hu) 2001-12-28
US6350736B1 (en) 2002-02-26
NO20006685L (no) 2001-02-28
CN1314909A (zh) 2001-09-26
JP2002519355A (ja) 2002-07-02
BR9911685A (pt) 2001-12-18
DE69920696T2 (de) 2006-03-02
EP1090018B1 (en) 2004-09-29
KR20010071673A (ko) 2001-07-31
US6528495B1 (en) 2003-03-04
WO2000000501A1 (en) 2000-01-06
NO20006685D0 (no) 2000-12-28
CA2336285A1 (en) 2000-01-06
EP1090018A1 (en) 2001-04-11
US20040171577A1 (en) 2004-09-02
US6537975B1 (en) 2003-03-25
US6030957A (en) 2000-02-29
US6670336B1 (en) 2003-12-30
US7071176B2 (en) 2006-07-04
AU4846999A (en) 2000-01-17
DE69920696D1 (de) 2004-11-04
HUP0102527A3 (en) 2002-04-29
ATE277940T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
IL140388A0 (en) Aryl phosphate derivatives of d4t having anti-hiv activity
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
AU5162796A (en) Novel peptide derivatives
PT810209E (pt) Hidroxietilamino-sulfonamidas de alfa- e beta-aminoacidos uteis como inibidores de protease retroviral
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
BG103485A (en) Ketobanzamides as calpain inhibitors
CA2266015A1 (en) Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
TR199903148T2 (xx) Antimetastatik ve antit�m�r etkinli�i olan barbit�rik asit t�revleri.
MX9706913A (es) Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
CA2278694A1 (en) Sulfamide-metalloprotease inhibitors
AU6797298A (en) Halo-alkoxycarbonyl prodrugs
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
WO1999058526A8 (en) Novel 2,5-pyridinedicarboxylic acid derivatives
ZA955793B (en) Benzothiadiazine compound process for its preparation and the pharmaceutical compositions which contain it
NZ213432A (en) Antihypertensive dipeptide derivatives and pharmaceutical compositions
DE60020891D1 (de) Arylphosphatderivate von d4t
AU4511299A (en) Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity
AU5589294A (en) Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
EP0355409A3 (en) Use of prolylendopeptidase inhibitors in the treatment of aids
DE69807857D1 (de) Antitumorale bisphosphonate mit alkylierenden einheiten
ES2104416T3 (es) Glicosilamidas de 2-aminoacilamino-2-desoxi-azucares.
IL129727A0 (en) 1-(3-Aminoindazol-5-YL)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
GR1002385B (el) Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν.